Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Research on the Safety and Efficacy of Blocking Dural Blood Supply in Glioblastoma Patients

NCT05990556 is registered in ClinicalTrials.gov with First Affiliated Hospital, Sun Yat-Sen University as lead sponsor.

NCT NCT05990556
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05990556 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Research on the Safety and Efficacy of Blocking Dural Blood Supply in Glioblastoma Patients
Lead sponsor
First Affiliated Hospital, Sun Yat-Sen University
Phase
Not applicable
Overall status
Recruiting
Start date
May 11, 2024
Completion date
September 1, 2028
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glioblastoma, meningeal arteries